《SG Analytics：2024医疗行业报告：医疗领域生成式AI应用案例及进展概述（英文版）（23页）.pdf》由会员分享，可在线阅读，更多相关《SG Analytics：2024医疗行业报告：医疗领域生成式AI应用案例及进展概述（英文版）（23页）.pdf（23页珍藏版）》请在三个皮匠报告上搜索。

1、2Healthcare Industry ReportExecutive SummaryKey Report HighlightsMarket OverviewGenerative AI and Digital TransformationRegulatory LandscapeEmerging Healthcare Trends-Surge in Healthcare Consolidation-Increased Outsourcing and Offshoring to Tackle Labor Shortages-Increased Investment in Outpatient S

2、ervices-Rising Demand for Weight-loss Drugs-Transition from Fee-for-Service Model to Value-based ModelFunding and Investment Landscape-Funding Outlook-Healthcare Sector Market Performance-Healthcare Deals in 2024CONTENTS010203040506073Healthcare Industry ReportThe US healthcare industry is on the cu

3、sp of significant growth,driven by a burgeoning and aging population of over 340 million,alongside regulatory tailwinds and technological advancements.In 2023,the industry grappled with various challenges,including workforce shortages,inflationary pressures,tight profit margins,disruptions in supply

4、 chains,and diminishing consumer trust within the intricate web of relationships between providers,payers,and patients.However,as we look to 2024,optimism surrounds emerging trends and investor interest in the industrys future.Generative AI(GenAI)is poised to play a pivotal role in addressing evolvi

5、ng consumer demands and the global scarcity of healthcare professionals.Its widespread adoption in clinical settings necessitates substantial investments in infrastructure,which is in its nascent stages,presenting lucrative opportunities for investors.Amidst a financially challenging landscape,the h

6、ealthcare sector seeks strategies such as consolidation,outsourcing,and emphasizing outpatient care to enhance cost-effectiveness and operational efficiency a trend likely to persist in the coming years.Additionally,the market dynamics are influenced by the introduction of new weight-loss drugs and